A team of students at Israel’s Ben-Gurion University competed in the 2018 International Genetically Engineered Competition (iGEM) at MIT in Boston. The group presented findings on a new therapeutic approach for Amyotropic Lateral Sclerosis (ALS), known also as Lou Gehrig’s disease.

http://www.winnipegjewishreview.com/article_detail.cfm?id=6845&sec=2